Lycopene Mitigates Cisplatin-Triggered Renal Injury in Sprague-Dawley Rat Model
DOI:
https://doi.org/10.59846/ajbas.v4i2.781Abstract
Background: Cisplatin is a commonly used chemotherapy drug that works well for various solid cancers. Nevertheless, its therapeutic effectiveness is restricted by the risk of nephrotoxicity,which can significantly impact long-term patient outcomes.
Problem: The problem addressed in this study is the nephrotoxicity associated with cisplatin treatment which can lead to kidney damage compromised renal performance.
Method: This study explored lycopene's (LP) potential to mitigate cisplatin-triggered renal injury in a Sprague Dawley rat model. The study consisted of five groups(n=5): a control group receiving normal saline, a group administered with cisplatin (10 mg/kg) , a group administered with lycopene (100 mg/kg), a group administered with cisplatin followed by lycopene, and a group administered with lycopene followed by cisplatin. The treatment lasted for 28 days.
Contribution: The study found that lycopene co-treatment mitigated cisplatin-triggered kidney damage,oxidative stress, and inflammation. Lycopene restored kidney antioxidant enzyme activities and diminished renal inflammation markers.Histopathological examination revealed that lycopene treatment reversed cisplatin-triggered kidney damage and promotedrenal tissue regeneration. These observations imply that lycopene may be a promising option for adjunctive therapy to reduce cisplatin-triggered nephrotoxicity.
References
Achkar IW, Abdulrahman N, Al-Sulaiti H, et al. Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway. J Transl Med. 2018;16(1):96. doi: 10.1186/s12967-018-1471-1
Elmorsy AE, Saber S, Hamad RS, et al. Advances in understanding cisplatin-induced toxicity: Molecular mechanisms and protective strategies. Eur J Pharm Sci. 2024;203:106939. doi: 10.1016/j.ejps.2024.106939
Volarevic V, Djokovic B, Jankovic MG, et al. Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. J Biomed Sci. 2019;26(1):25. doi: 10.1186/s12929-019-0518-9
Oh GS, Kim HJ, Shen A, et al. Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies. Electrolyte Blood Press. 2014;12(2):55-65. doi: 10.5049/EBP.2014.12.2.55
McSweeney KR, Gadanec LK, Qaradakhi T, et al. Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations. Cancers. 2021;13(7):1572. doi: 10.3390/cancers13071572
Jana S, Mitra P, Dutta A, et al. Early diagnostic biomarkers for acute kidney injury using cisplatin-induced nephrotoxicity in rat model. Curr Res Toxicol. 2023;5:100135. doi: 10.1016/j.crtox.2023.100135
Shi M, McMillan KL, Wu J, et al. Cisplatin nephrotoxicity as a model of chronic kidney disease. Lab Invest. 2018;98(8):1105-1118.
Caseiro M, Ascenso A, Costa A, et al. Lycopene in human health. LWT. 2020;127:109323. doi: 10.1016/j.lwt.2020.109323
Tvrdá E, Kováčik A, Tušimová E, et al. Antioxidant efficiency of lycopene on oxidative stress-induced damage in bovine spermatozoa. J Anim Sci Biotechnol. 2016;7(1):50. doi: 10.1186/s40104-016-0113-9
Burton-Freeman BM, Sesso HD. Whole Food versus Supplement: Comparing the Clinical Evidence of Tomato Intake and Lycopene Supplementation on Cardiovascular Risk Factors. Adv Nutr. 2014;5(5):457-485. doi: 10.3945/an.114.005231
Karaköy Z, Cadirci E, Dincer B. A new target in inflammatory diseases: Lycopene. Eurasian J Med. 2022;54(Suppl 1):S23-S28.
Pan X, Zhu R, Peng J, et al. Molecular mechanisms and potential targets of lycopene for alleviating renal ischemia-reperfusion injury revealed by network pharmacology and animal experiments. Int Immunopharmacol. 2024;143(Pt 2):113421. doi: 10.1016/j.intimp.2024.113421
Imran M, Ghorat F, Ul-Haq I, et al. Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders. Antioxidants. 2020;9(8):706. doi: 10.3390/antiox9080706
Treacy O, Brown N, Dimeski G. Biochemical evaluation of kidney disease. Transl Androl Urol. 2018;8(Suppl 2):S214-S223. doi: 10.21037/tau.2018.10.02
Pérez-Severiano F, Santamaría A, Pedraza-Chaverri J, et al. Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington’s disease mutation. Neurochem Res. 2004;29(4):729-733.
Adedara IA, Abolaji AO, Rocha JB, Farombi EO. Diphenyl diselenide protects against mortality, locomotor deficits, and oxidative stress in Drosophila melanogaster model of manganese-induced neurotoxicity. Neurochem Res. 2016;41(5):1430-1438.
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal Biochem. 1982;126(1):131-138.
Granell S, Gironella M, Bulbena O, Panés J, Mauri M, Sabater L, et al. Heparin mobilizes xanthine oxidase and induces lung inflammation in acute pancreatitis. Crit Care Med. 2003;31(2):525-530.
Siyanbade JA, Iteire KA, Adelakun SA, Adebisi KA, Kehinde BD, Akwu BP, et al. Colocasia esculenta Leaf Extract Mitigates Hippocampal Injury Caused by Lipopolysaccharide in Mice. Trop J Nat Prod Res. 2024;8(9):8438-8446. doi: 10.26538/tjnpr/v8i9.28
Adelakun SA, Akomaye AJ, Omotoso OD, Arowosegbe OA. Anti-hepatopathy and anti-nephropathy activities of Taraxacum officinale in a rat model of Streptozotocin diabetes-induced hepatorenal toxicity and dyslipidemia via attenuation of oxidative stress, inflammation, apoptosis, electrolyte imbalances, and mitochondrial dysfunction. Aspects Mol Med. 2024;3:100034. doi: 10.1016/j.amolm.2024.100034
Bin-Jumah MN, Nadeem MS, Gilani SJ, et al. Lycopene: A Natural Arsenal in the War against Oxidative Stress and Cardiovascular Diseases. Antioxidants (Basel). 2022;11(2):232. doi: 10.3390/antiox11020232
Park J, Sim J, Yi HJ, et al. Cisplatin induces kidney damage through the down-regulation of Prx I by autophagic degradation. Free Radic Biol Med. 2024;225:236-246. doi: 10.1016/j.freeradbiomed.2024.01.021
Varela ELP, Gomes ARQ, da Silva Barbosa Dos Santos A, et al. Potential Benefits of Lycopene Consumption: Rationale for Using It as an Adjuvant Treatment for Malaria Patients and in Several Diseases. Nutrients. 2022;14(24):5303. doi: 10.3390/nu14245303
24. McSweeney KR, Gadanec LK, Qaradakhi T, et al. Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations. Cancers (Basel). 2021;13(7):1572. doi: 10.3390/cancers13071572
Karaköy Z, Cadirci E, Dincer B. A new target in inflammatory diseases: Lycopene. Eurasian J Med. 2022;54(Suppl 1):S23-S28.
Türk G, Ceribaşi AO, Sakin F, et al. Antiperoxidative and anti-apoptotic effects of lycopene and ellagic acid on cyclophosphamide-induced testicular lipid peroxidation and apoptosis. Reprod Fertil Dev. 2010;22(4):587-596. doi: 10.1071/RD09078
Fang C, Lou D, Zhou L, et al. Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin. 2021;42(12):1951-1969. doi: 10.1038/s41401-021-00620-9
Pan X, Zhu R, Peng J, et al. Molecular mechanisms and potential targets of lycopene for alleviating renal ischemia-reperfusion injury revealed by network pharmacology and animal experiments. Int Immunopharmacol. 2024;143(Pt 2):113421. doi: 10.1016/j.intimp.2024.113421
Wang Y, Liu Z, Ma J, Xv Q, Gao H, Yin H, et al. Lycopene attenuates the inflammation and apoptosis in aristolochic acid nephropathy by targeting the Nrf2 antioxidant system. Redox Biol. 2022;57:102494. doi: 10.1016/j.redox.2022.102494
Gori P, Patel A, Solanki N, Shah U, Patel V, Patel S. Protective effects of lycopene against adenine-induced chronic renal failure in rats. Indian J
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Sunday Aderemi Adelakun , Jacob Adewale Siyanbade , Peter Bala Akwu, Victor Oyetayo Olawuyi
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in Abhath Journal of Basic and Applied Sciences (AJOBAS) are open-access and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows users to freely share, copy, distribute, and adapt the work, provided that the original author(s) and source are properly credited.
